BAP1 - uveal melanoma, hereditary

This test is available for the following conditions:

  • Conditions > Oncogenetics > Uveal melanoma, hereditary
  • Conditions > Vision impairment / blindness > Uveal melanoma, hereditary

This product is also part of the following panels:

  • panel hereditary renalcancer (SDHA, SDHB, SDHC, SDHD, SDHAF2, VHL, PTEN, FLCN, MET, FH, BAP1)
  • panel Melanoma, extensive (CDKN2A, CDK4, MITF p.(Glu318Lys), BAP1, POT1, TERT promoter)¹
  • panel Melanoma, extensive (CDKN2A, CDK4, MITF p.(Glu318Lys), BAP1, POT1, TERT promoter)¹
  • WES hereditary cancer (% *)
  • WES intellectual disability (% *)
  • WES Mendelian inherited disorders (% *)
  • WES skin disorders¹ (% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

  • Sequence analysis of all coding exons and flanking intron-exon boundaries
  • Deletion/duplication analysis (MLPA)

OMIM: 603089
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane




€ 707

Gene

BAP1 - uveal melanoma, hereditary

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks
Performing laboratory
Radboudumc
€ 707

BAP1 - uveal melanoma, hereditary



€ 707